Polymorphisms in CCR6 Are Associated with Chronic Graft-versus-Host Disease and Invasive Fungal Disease in Matched-Related Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 10, 2011, Pages 1443-1449

  Broen, Kelly ^a   Van Der Waart, Anniek B ^a   Greupink Draaisma, Annelies ^a   Metzig, Julia ^a   Feuth, Ton ^a   Schaap, Nicolaas P M ^a   Blijlevens, Nicole M A ^a   Van Der Velden, Walter J F M ^a   Dolstra, Harry ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alloreactivity; Bone marrow transplantation; IL 23R; Single nucleotide polymorphism

Indexed keywords

CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 23 RECEPTOR;

ADULT; ALLELE; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DONOR; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC MYCOSIS; T CELL DEPLETION; TREATMENT OUTCOME;

ADULT; ALLELES; CHRONIC DISEASE; GENOTYPE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNITY, CELLULAR; MALE; MIDDLE AGED; MYCOSES; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR6; RECEPTORS, INTERLEUKIN; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; UNRELATED DONORS;

EID: 80052977123     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.07.004     Document Type: Article

References (40)

1. Baddley J.W., Andes D.R., Marr K.A., et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis 2010, 50:1559-1567.
2. Ferrara J.L., Levine J.E., Reddy P., et al. Graft-versus-host disease. Lancet 2009, 373:1550-1561.
3. Lee S.J., Vogelsang G., Flowers M.E. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003, 9:215-233.
4. Toubai T., Sun Y., Reddy P. GVHD pathophysiology: is acute different from chronic?. Best Pract Res Clin Haematol 2008, 21:101-117.
5. Miossec P., Korn T., Kuchroo V.K. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009, 361:888-898.
6. Annunziato F., Romagnani S. Do studies in humans better depict Th17 cells?. Blood 2009, 114:2213-2219.
7. Costa-Rodriguez E.V., Rivino L., Geginat J., et al. Surface phenotype and antigenic specificity of human interleukin-17-producing T helper memory cells. Nat Immunol 2007, 8:639-646.
8. Wang C., Kang S.G., Lee J., et al. The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol 2009, 2:173-183.
9. Khader S.A., Gaffen S.L., Kolls J.K. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol 2009, 2:403-411.
10. Van de Veerdonk F.L., Gresnigt M.S., Kullberg B.J., et al. Th17 responses and host defense against microorganisms: an overview. BMB Rep 2009, 42:776-787.
11. Steinman L. Mixed results with modulation of TH-17 cells in human autoimmune diseases. Nat Immunol 2010, 11:41-44.
12. Litjens N.H., Van de Wetering J., Van Besouw N.M., et al. The human alloreactive CD4+ T-cell repertoire is biased to a Th17 response, and the frequency is inversely related to the number of HLA class II mismatches. Blood 2009, 114:3947-3955.
13. Benghiat F.S., Charbonnier L.M., Vokaer B., et al. Interleukin-17-producing T helper cells in alloimmunity. Transplant Rev (Orlando) 2009, 23:11-18.
14. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006, 6:295-307.
15. Carlson M.J., West M.L., Coghill J.M., et al. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood 2009, 113:1365-1374.
16. Chen X., Vodanovic-Jankovic S., Johnson B., et al. Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood 2007, 110:3804-3813.
17. Elmaagacli A.H., Koldehoff M., Landt O., et al. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic cell transplantation. Bone Marrow Transplant 2008, 41:821-826.
18. Gruhn B., Intek J., Pfaffendorf N., et al. Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children. Biol Blood Marrow Transplant 2009, 15:1571-1577.
19. Wermke M., Maiwald S., Schmelz R., et al. Genetic variations of IL23R(1143A>G) and BPI(A645G) but not NOD2 are associated with acute GvHD after allogeneic transplantation. Biol Blood Marrow Transplant 2010, 16:1718-1727.
20. Mullally A., Ritz J. Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Blood 2007, 109:1355-1362.
21. Van der Velden W.J., Blijlevens N.M., Maas F.M., et al. NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation. Bone Marrow Transplant 2009, 44:243-248.
22. Kochi Y., Okada Y., Suzuki A., et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet 2010, 42:515-519.
23. Barrett J.C., Hansoul S., Nicolae D.L., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40:955-962.
24. Schaap N., Schattenberg A., Bar B., et al. Outcome of transplantation for standard-risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen. Br J Haematol 1997, 98:750-759.
25. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
26. De Pauw B., Walsh T.J., Donnelly J.P., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
27. MacGregor R.R., Beaty H.N. Evaluation of positive blood cultures: guidelines for early differentiation of contaminated from valid positive cultures. Arch Intern Med 1972, 130:84-87.
28. Safrany E., Pazar B., Csongei V., et al. Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjo{double acute}gren syndrome in Hungarian population samples. Scand J Immunol 2009, 70:68-74.
29. Chai L.Y., de Boer M.G., Van der Velden W.J., et al. The Y238X stop codon polymorphism in the human β-glucan receptor dectin-1 and susceptibility to invasive aspergillosis. J Infect Dis 2011, 203:736-743.
30. Cunha C., Di Lanni M., Bozza S., et al. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. Blood 2010, 116:5394-5402.
31. Plantinga T.S., Van der Velden W.J., Ferwerda B., et al. Early stop polymorphism in human DECTIN-1 is associated with increased Candida colonization in hematopoietic stem cell transplant recipients. Clin Infect Dis 2009, 49:724-732.
32. Nguyen Y., Al-Lehibi A., Gorbe E., et al. Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation. Blood 2010, 115:3625-3631.
33. Rimoldi M., Chieppa M., Salucci V., et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005, 6:507-514.
34. Penack O., Smith O.M., Cunningham-Bussel A., et al. NOD2 regulates hematopoietic cell function during graft-versus-host disease. J Exp Med 2009, 206:2101-2110.
35. Chai L.Y., Van der Velden W.J., Marijnissen R.J., et al. Anti-aspergillus human host defense relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. Immunology 2010, 130:46-54.
36. Zelante T., De Luca A., Bonifazi P., et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007, 37:2695-2706.
37. Salazar-Gonzalez R.M., Niess J.H., Zammit D.J., et al. CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches. Immunity 2006, 24:623-632.
38. Phadke A.P., Akangire G., Park S.J., et al. The role of CC chemokine receptor 6 in host defense in a model of invasive pulmonary aspergillosis. Am J Respir Crit Care Med 2007, 175:1165-1172.
39. Dander E., Balduzzi A., Zappa G., et al. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Transplantation 2009, 88:1261-1272.
40. Werner J.L., Metz A.E., Horn D., et al. Requisite role for the dectin-1 β-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol 2009, 182:4938-4946.